Abstract
Heart failure due to dilated cardiomyopathy is associated with a significant increase in risk of thromboembolism. The incidence can be estimated, on the average, at 2.0-2.5 events per 100 patients per year. At this time, in the absence of randomized trials, limited evidence exists to support the use of anticoagulant treatment for patients with heart failure due to dilated cardiomyopathy in sinus rhythm, even if these subjects appear to be at higher risk than those with ischemic cardiomyopathy and comparable degree of left ventricular dysfunction. Women with left ventricular ejection fraction
| Original language | Italian |
|---|---|
| Pages (from-to) | 227-232 |
| Number of pages | 6 |
| Journal | Annali Italiani di Medicina Interna |
| Volume | 13 |
| Issue number | 4 |
| Publication status | Published - 1998 |
Fingerprint
ASJC Scopus subject areas
- Internal Medicine
Cite this
La terapia anticoagulante nel paziente con miocardiopatia dilatativa. / Gensini, G. F.; Rostagno, C.
In: Annali Italiani di Medicina Interna, Vol. 13, No. 4, 1998, p. 227-232.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - La terapia anticoagulante nel paziente con miocardiopatia dilatativa
AU - Gensini, G. F.
AU - Rostagno, C.
PY - 1998
Y1 - 1998
N2 - Heart failure due to dilated cardiomyopathy is associated with a significant increase in risk of thromboembolism. The incidence can be estimated, on the average, at 2.0-2.5 events per 100 patients per year. At this time, in the absence of randomized trials, limited evidence exists to support the use of anticoagulant treatment for patients with heart failure due to dilated cardiomyopathy in sinus rhythm, even if these subjects appear to be at higher risk than those with ischemic cardiomyopathy and comparable degree of left ventricular dysfunction. Women with left ventricular ejection fraction
AB - Heart failure due to dilated cardiomyopathy is associated with a significant increase in risk of thromboembolism. The incidence can be estimated, on the average, at 2.0-2.5 events per 100 patients per year. At this time, in the absence of randomized trials, limited evidence exists to support the use of anticoagulant treatment for patients with heart failure due to dilated cardiomyopathy in sinus rhythm, even if these subjects appear to be at higher risk than those with ischemic cardiomyopathy and comparable degree of left ventricular dysfunction. Women with left ventricular ejection fraction
UR - http://www.scopus.com/inward/record.url?scp=0032423122&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032423122&partnerID=8YFLogxK
M3 - Articolo
C2 - 10349204
AN - SCOPUS:0032423122
VL - 13
SP - 227
EP - 232
JO - Annali Italiani di Medicina Interna
JF - Annali Italiani di Medicina Interna
SN - 0393-9340
IS - 4
ER -